Relevance and challenges in modeling human gastric and small intestinal digestion

Trends in Biotechnology

Volumn 30, Issue 11, 2012, Pages 591-600

  Guerra, Aurélie ^a   Etienne Mesmin, Lucie ^a   Livrelli, Valérie ^a   Denis, Sylvain ^a   Blanquet Diot, Stéphanie ^a   Alric, Monique ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Human digestion; In vitro models; Stomach and small intestine

Indexed keywords

BIOLOGICAL SIGNIFICANCE; DIGESTION TECHNOLOGY; GROWING DEMAND; HUMAN DIGESTION; IN-VITRO; IN-VIVO; SMALL INTESTINE; SMALL-INTESTINAL DIGESTION; TECHNOLOGICAL COMPLEXITY; TECHNOLOGICAL INNOVATION;

BIOTECHNOLOGY;

BIOTECHNOLOGY; COMPARTMENT MODEL; DIGESTION; GASTROINTESTINAL TRACT; NUTRITION; PRIORITY JOURNAL; REVIEW;

DIGESTION; HUMANS; INTESTINE, SMALL; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; STOMACH;

EID: 84867698101     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2012.08.001     Document Type: Review

References (91)

1. Dean J.R., Ma R. Approaches to assess the oral bioaccessibility of persistent organic pollutants: a critical review. Chemosphere 2007, 68:1399-1407.
2. Parada J., Aguilera J.M. Food microstructure affects the bioavailability of several nutrients. J. Food Sci. 2007, 72:R21-R32.
3. McAllister M. Dynamic dissolution: a step closer to predictive dissolution testing?. Mol. Pharm. 2010, 7:1374-1387.
4. Hur S.J., et al. In vitro human digestion models for food applications. Food Chem. 2011, 125:1-12.
5. Yvon M., et al. In vitro simulation of gastric digestion of milk proteins: comparison between in vitro and in vivo data. J. Agric. Food Chem. 1992, 40:239-244.
6. Vatier J., et al. Interests of the 'artificial stomach' techniques to study antacid formulations: comparison with in vivo evaluation. Fundam. Clin. Pharmacol. 1998, 12:573-583.
7. Mainville I., et al. A dynamic model that simulates the human upper gastrointestinal tract for the study of probiotics. Int. J. Food Microbiol. 2005, 99:287-296.
8. Minekus M., et al. A multicompartmental dynamic computer-controlled model simulating the stomach and small intestine. ATLA 1995, 23:197-209.
9. Meullenet J.F., Gandhapuneni R.K. Development of the BITE Master II and its application to the study of cheese hardness. Physiol. Behav. 2006, 89:39-43.
10. Salles C., et al. Development of a chewing simulator for food breakdown and the analysis of in vitro flavor compound release in a mouth environment. J. Food Eng. 2007, 82:189-198.
11. Macfarlane G.T., Macfarlane S. Models for intestinal fermentation: association between food components, delivery systems, bioavailability and functional interactions in the gut. Curr. Opin. Biotechnol. 2007, 18:156-162.
12. Payne A.N., et al. Advances and perspectives in in vitro human gut fermentation modeling. Trends Biotechnol. 2012, 30:17-25.
13. Woda A., et al. Development and validation of a mastication simulator. J. Biomech. 2010, 43:1667-1673.
14. Barrett K.E. Gastrointestinal Physiology 2006, Lange Medical Books/McGraw-Hill.
15. Kong F., Singh R.P. Disintegration of solid foods in human stomach. J. Food Sci. 2008, 73:R67-R80.
16. Golding M., Wooster T.J. The influence of emulsion structure and stability on lipid digestion. Curr. Opin. Colloid Interface Sci. 2010, 15:90-101.
17. Ballance S., et al. Evaluation of gastric processing and duodenal digestion of starch in six cereal meals on the associated glycaemic response using an adult fasted dynamic gastric model. Eur. J. Nutr. 2012, 10.1007/s00394-012-0386-5.
18. Booijink C.C., et al. High temporal and inter-individual variation detected in the human ileal microbiota. Environ. Microbiol. 2010, 12:3213-3227.
19. van den Bogert B., et al. Microarray analysis and barcoded pyrosequencing provide consistent microbial profiles depending on the source of human intestinal samples. Appl. Environ. Microbiol. 2011, 77:2071-2080.
20. Schubert M.L. Hormonal regulation of gastric acid secretion. Curr. Gastroenterol. Rep. 2008, 10:523-527.
21. Mayer E.A. Gut feelings: the emerging biology of gut-brain communication. Nat. Rev. Neurosci. 2011, 12:453-466.
22. Mason K.L., et al. Overview of gut immunology. Adv. Exp. Med. Biol. 2008, 635:1-14.
23. Babinszky L., et al. An in vitro method for prediction of the digestible crude protein content in pig feeds. J. Sci. Food Agric. 1990, 50:173-178.
24. Englyst H.N., et al. Measurement of resistant starch in vitro and in vivo. Br. J. Nutr. 1996, 75:749-755.
25. Garrett D.A., et al. Development of an in vitro digestion method to assess carotenoid bioavailability from meals. J. Agric. Food Chem. 1999, 47:4301-4309.
26. Oomen A.G., et al. Development of an in vitro digestion model for estimating the bioaccessibility of soil contaminants. Arch. Environ. Contam. Toxicol. 2003, 44:281-287.
27. Chen J., et al. Development of a simple model device for in vitro gastric digestion investigation. Food Funct. 2011, 2:174-182.
28. Miller D.D., et al. An in vitro method for estimation of iron availability from meals. Am. J. Clin. Nutr. 1981, 34:2248-2256.
29. Hoebler C., et al. Development of an in vitro system simulating bucco-gastric digestion to assess the physical and chemical changes of food. Int. J. Food Sci. Nutr. 2002, 53:389-402.
30. Mercuri A., et al. The effect of composition and gastric conditions on the self-emulsification process of ibuprofen-loaded self-emulsifying drug delivery systems: a microscopic and dynamic gastric model study. Pharm. Res. 2011, 28:1540-1551.
31. Vardakou M., et al. Achieving antral grinding forces in biorelevant in vitro models: comparing the USP Dissolution Apparatus II and the Dynamic Gastric Model with human in vivo data. AAPS Pharm. Sci. Tech. 2011, 12:620-626.
32. Kong F., Singh R.P. A human gastric simulator (HGS) to study food digestion in human stomach. J. Food Sci. 2010, 75:E627-E635.
33. Kong F., et al. Physical changes in white and brown rice during simulated gastric digestion. J. Food Sci. 2011, 76:E450-E457.
34. Castela-Papin N., et al. Drug interactions with diosmectite: a study using the artificial stomach-duodenum model. Int. J. Pharm. 1999, 182:111-119.
35. Tompkins T.A., et al. The impact of meals on a probiotic during transit through a model of the human upper gastrointestinal tract. Benef. Microbes 2011, 2:295-303.
36. Blanquet-Diot S., et al. Digestive stability of xanthophylls exceeds that of carotenes as studied in a dynamic in vitro gastrointestinal system. J. Nutr. 2009, 139:876-883.
37. Martin A.H., de Jong G.A. Enhancing the in vitro Fe(2+) bio-accessibility using ascorbate and cold-set whey protein gel particles. Dairy Sci. Technol. 2012, 92:133-149.
38. Krul C.A., et al. Intragastric formation and modulation of N-nitrosodimethylamine in a dynamic in vitro gastrointestinal model under human physiological conditions. Food Chem. Toxicol. 2004, 42:51-63.
39. Torres-Escribano S., et al. Comparison of a static and a dynamic in vitro model to estimate the bioaccessibility of As, Cd, Pb and Hg from food reference materials Fucus sp. (IAEA-140/TM) and Lobster hepatopancreas (TORT-2). Sci. Total Environ. 2011, 409:604-611.
40. Brouwers J., et al. Food-dependent disintegration of immediate release fosamprenavir tablets: in vitro evaluation using magnetic resonance imaging and a dynamic gastrointestinal system. Eur. J. Pharm. Biopharm. 2011, 77:313-319.
41. Dickinson P.A., et al. An investigation into the utility of a multi-compartmental, dynamic, system of the upper gastrointestinal tract to support formulation development and establish bioequivalence of poorly soluble drugs. AAPS J. 2012, 14:196-205.
42. Kheadr E., et al. Study of the physicochemical and biological stability of pediocin PA-1 in the upper gastrointestinal tract conditions using a dynamic in vitro model. J. Appl. Microbiol. 2010, 109:54-64.
43. Blanquet-Diot S., et al. Use of artificial digestive systems to investigate the biopharmaceutical factors influencing the survival of probiotic yeast during gastrointestinal transit in humans. Pharm. Res. 2012, 29:1444-1453.
44. Gervais R., et al. Bioaccessibility of fatty acids from conjugated linoleic acid-enriched milk and milk emulsions studied in a dynamic in vitro gastrointestinal model. Int. Dairy J. 2009, 19:574-581.
45. Kopf-Bolanz K.A., et al. Validation of an in vitro digestive system for studying macronutrient decomposition in humans. J. Nutr. 2012, 142:245-250.
46. Anson N.M., et al. Bioprocessing of wheat bran improves in vitro bioaccessibility and colonic metabolism of phenolic compounds. J. Agric. Food Chem. 2009, 57:6148-6155.
47. Failla M.L., et al. In vitro micellarization and intestinal cell uptake of cis isomers of lycopene exceed those of all-trans lycopene. J. Nutr. 2008, 138:482-486.
48. Tydeman E.A., et al. Effect of carrot (Daucus carota) microstructure on carotene bioaccessibility in the upper gastrointestinal tract. 1. In vitro simulations of carrot digestion. J. Agric. Food Chem. 2010, 58:9847-9854.
49. Verwei M., et al. The effect of folate-binding proteins on bioavailability of folate from milk products. Trends Food Sci. Technol. 2005, 16:307-310.
50. Lesmes U., McClements D.J. Controlling lipid digestibility: response of lipid droplets coated by β-lactoglobulin-dextran Maillard conjugates to simulated gastrointestinal conditions. Food Hydrocolloids 2012, 26:221-230.
51. Van Buggenhout S., et al. In vitro approaches to estimate the effect of food processing on carotenoid bioavailability need thorough understanding of process induced microstructural changes. Trends Food Sci. Technol. 2010, 21:607-618.
52. Salovaara S., et al. Prolonged transit time through the stomach and small intestine improves iron dialyzability and uptake in vitro. J. Agric. Food Chem. 2003, 51:5131-5136.
53. Epriliati I., et al. Nutriomic analysis of fresh and processed fruit products. 1. During in vitro digestions. J. Agric. Food Chem. 2009, 57:3363-3376.
54. Moreno F.J. Gastrointestinal digestion of food allergens: effect on their allergenicity. Biomed. Pharmacother. 2007, 61:50-60.
55. Pelfrene A., et al. Bioaccessibility of trace elements as affected by soil parameters in smelter-contaminated agricultural soils: a statistical modeling approach. Environ. Pollut. 2012, 160:130-138.
56. He M., Wang W.X. Factors affecting the bioaccessibility of methylmercury in several marine fish species. J. Agric. Food Chem. 2011, 59:7155-7162.
57. Oomen A.G., et al. Effect of bile type on the bioaccessibility of soil contaminants in an in vitro digestion model. Arch. Environ. Contam. Toxicol. 2004, 46:183-188.
58. Pelfrene A., et al. In vitro digestion and DGT techniques for estimating cadmium and lead bioavailability in contaminated soils: influence of gastric juice pH. Sci. Total Environ. 2011, 409:5076-5085.
59. Wickham M., et al. In vitro digestion methods for assessing the effect of food structure on allergen breakdown. Mol. Nutr. Food Res. 2009, 53:952-958.
60. Untersmayr E., Jensen-Jarolim E. The role of protein digestibility and antacids on food allergy outcomes. J. Allergy Clin. Immunol. 2008, 121:1301-1310.
61. Moreno F.J., et al. Phospholipid interactions protect the milk allergen alpha-lactalbumin from proteolysis during in vitro digestion. J. Agric. Food Chem. 2005, 53:9810-9816.
62. Mitea C., et al. Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease. Gut 2008, 57:25-32.
63. Garbacz G., et al. Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses. Eur. J. Pharm. Sci. 2009, 38:147-155.
64. Gu C.H., et al. Using a novel multicompartment dissolution system to predict the effect of gastric pH on the oral absorption of weak bases with poor intrinsic solubility. J. Pharm. Sci. 2005, 94:199-208.
65. Vardakou M., et al. Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model. Int. J. Pharm. 2011, 419:192-199.
66. Tenjarla S., et al. Release of 5-aminosalicylate from an MMX mesalamine tablet during transit through a simulated gastrointestinal tract system. Adv. Ther. 2007, 24:826-840.
67. Souliman S., et al. A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form. Eur. J. Pharm. Sci. 2006, 27:72-79.
68. Blanquet S., et al. The 'biodrug' concept: an innovative approach to therapy. Trends Biotechnol. 2001, 19:393-400.
69. Ritter P., et al. Evaluation of the passage of Lactobacillus gasseri K7 and bifidobacteria from the stomach to intestines using a single reactor model. BMC Microbiol. 2009, 9:87.
70. Lo Curto A., et al. Survival of probiotic lactobacilli in the upper gastrointestinal tract using an in vitro gastric model of digestion. Food Microbiol. 2011, 28:1359-1366.
71. Bergholz T.M., Whittam T.S. Variation in acid resistance among enterohaemorrhagic Escherichia coli in a simulated gastric environment. J. Appl. Microbiol. 2007, 102:352-362.
72. Marteau P., et al. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. J. Dairy Sci. 1997, 80:1031-1037.
73. Etienne-Mesmin L., et al. Effect of a new probiotic Saccharomyces cerevisiae strain on survival of Escherichia coli O157:H7 in a dynamic gastrointestinal model. Appl. Environ. Microbiol. 2011, 77:1127-1131.
74. Deat E., et al. Combining the dynamic TNO-gastrointestinal tract system with a Caco-2 cell culture model: application to the assessment of lycopene and alpha-tocopherol bioavailability from a whole food. J. Agric. Food Chem. 2009, 57:11314-11320.
75. Epriliati I., et al. Nutriomic analysis of fresh and processed fruit products. 2. During in vitro simultaneous molecular passages using Caco-2 cell monolayers. J. Agric. Food Chem. 2009, 57:3377-3388.
76. Motz S.A., et al. Permeability assessment for solid oral drug formulations based on Caco-2 monolayer in combination with a flow through dissolution cell. Eur. J. Pharm. Biopharm. 2007, 66:286-295.
77. Vasiluk L., et al. In vitro estimates of bioaccessible nickel in field-contaminated soils, and comparison with in vivo measurement of bioavailability and identification of mineralogy. Sci. Total Environ. 2011, 409:2700-2706.
78. Frontela-Saseta C., et al. Evaluation of antioxidant activity and antiproliferative effect of fruit juices enriched with Pycnogenol(R) in colon carcinoma cells. The effect of in vitro gastrointestinal digestion. Phytother. Res. 2011, 25:1870-1875.
79. Laparra J.M., Sanz Y. Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion. J. Cell. Biochem. 2010, 109:801-807.
80. Siegel J.A., et al. Biphasic nature of gastric emptying. Gut 1988, 29:85-89.
81. Molly K., et al. Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem. Appl. Microbiol. Biotechnol. 1993, 39:254-258.
82. Marzorati M., et al. In vitro modulation of the human gastrointestinal microbial community by plant-derived polysaccharide-rich dietary supplements. Int. J. Food Microbiol. 2010, 139:168-176.
83. Fassler C., et al. In vitro fermentability of differently digested resistant starch preparations. Mol. Nutr. Food Res. 2006, 50:1220-1228.
84. Maathuis A.J., et al. Galacto-oligosaccharides have prebiotic activity in a dynamic in vitro colon model using a C-labeling technique. J. Nutr. 2012, 142:1205-1212.
85. Maccaferri S., et al. In vitro fermentation of potential prebiotic flours from natural sources: Impact on the human colonic microbiota and metabolome. Mol. Nutr. Food Res. 2012, 56:1342-1352.
86. Payne A.N., et al. The composition and metabolic activity of child gut microbiota demonstrate differential adaptation to varied nutrient loads in an in vitro model of colonic fermentation. FEMS Microbiol. Ecol. 2012, 80:608-623.
87. Blanquet S., et al. A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions. Pharm. Res. 2004, 21:585-591.
88. Dupont D., et al. Comparative resistance of food proteins to adult and infant in vitro digestion models. Mol. Nutr. Food Res. 2010, 54:767-780.
89. Hawcutt D.B., Smyth R.L. Drug development for children: how is pharma tackling an unmet need?. IDrugs 2008, 11:502-507.
90. Vermeiren J., et al. Decreased colonization of fecal Clostridium coccoides/Eubacterium rectale species from ulcerative colitis patients in an in vitro dynamic gut model with mucin environment. FEMS Microbiol. Ecol. 2012, 79:685-696.
91. Van de Wiele T.R., et al. Comparison of five in vitro digestion models to in vivo experimental results: lead bioaccessibility in the human gastrointestinal tract. J. Environ. Sci. Health. A: Tox. Hazard. Subst. Environ. Eng. 2007, 42:1203-1211.